Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,801 to 1,820 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies. | Front Immunol | 2019 | 31396241 | PubTator, text mining | PubMed |
| ORMDL3 and allergic asthma: From physiology to pathology. | J Allergy Clin Immunol | 2019 | 31376405 | PubTator, text mining | PubMed |
| Phc2 controls hematopoietic stem and progenitor cell mobilization from bone marrow by repressing Vcam1 expression. | Nat Commun | 2019 | 31375680 | PubTator, text mining | PubMed |
| Candidate genes and pathways associated with brain metastasis from lung cancer compared with lymph node metastasis. | Exp Ther Med | 2019 | 31363372 | PubTator, text mining | PubMed |
| CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression. | Int J Biol Sci | 2019 | 31360109 | PubTator, text mining | PubMed |
| Early T Cell Differentiation with Well-Maintained Function across the Adult Life Course in Sub-Saharan Africa. | J Immunol | 2019 | 31358657 | PubTator, text mining | PubMed |
| Innate Immune Cells and Toll-like Receptor-Dependent Responses at the Maternal-Fetal Interface. | Int J Mol Sci | 2019 | 31357391 | PubTator, text mining | PubMed |
| Equine arteritis virus long-term persistence is orchestrated by CD8+ T lymphocyte transcription factors, inhibitory receptors, and the CXCL16/CXCR6 axis. | PLoS Pathog | 2019 | 31356622 | PubTator, text mining | PubMed |
| First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors. | J Immunother Cancer | 2019 | 31340866 | PubTator, text mining | PubMed |
| Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile. | Cancers (Basel) | 2019 | 31330834 | PubTator, text mining | PubMed |
| An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More. | Front Immunol | 2019 | 31316503 | PubTator, text mining | PubMed |
| Comprehensive Gene Expression Analysis in NMIBC Using RNA-seq Reveals New Therapy Strategies. | Front Oncol | 2019 | 31293967 | PubTator, text mining | PubMed |
| OMIP-059: Identification of Mouse Hematopoietic Stem and Progenitor Cells with Simultaneous Detection of CD45.1/2 and Controllable Green Fluorescent Protein Expression by a Single Staining Panel. | Cytometry A | 2019 | 31282128 | PubTator, text mining | PubMed |
| Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer. | Front Immunol | 2019 | 31281312 | PubTator, text mining | PubMed |
| Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice. | Arch Toxicol | 2019 | 31278416 | PubTator, text mining | PubMed |
| The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Session. | Bone Marrow Transplant | 2019 | 31270397 | PubTator, text mining | PubMed |
| NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing. | J Exp Med | 2019 | 31270246 | PubTator, text mining | PubMed |
| CD166 Engagement Augments Mouse and Human Hematopoietic Progenitor Function via Activation of Stemness and Cell Cycle Pathways. | Stem Cells | 2019 | 31260147 | PubTator, text mining | PubMed |
| C/EBPβ-LIP induces cancer-type metabolic reprogramming by regulating the let-7/LIN28B circuit in mice. | Commun Biol | 2019 | 31240246 | PubTator, text mining | PubMed |
| Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. | Front Immunol | 2019 | 31231370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=91